Dexmedetomidine versus magnesium sulphate as an adjuvant to local anesthesia in single-injection percutaneous peribulbar anesthesia for cataract extraction

Abstract Background The aim of the study was to evaluate the impact of addition of dexmedetomidine or magnesium sulphate to the standard local anesthetics mixture as a primary objective and to compare between both as a secondary objective utilizing the single-injection percutaneous technique for per...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aya Abuelyossr M., N. A. Mohammad, Khaled M. Maghawry, Maha Sadek Elderh, Mai Mohsen AbdulAziz
Formato: article
Lenguaje:EN
Publicado: SpringerOpen 2021
Materias:
Acceso en línea:https://doaj.org/article/7336cc6852bb43c299eed63042c4f295
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7336cc6852bb43c299eed63042c4f295
record_format dspace
spelling oai:doaj.org-article:7336cc6852bb43c299eed63042c4f2952021-11-21T12:04:50ZDexmedetomidine versus magnesium sulphate as an adjuvant to local anesthesia in single-injection percutaneous peribulbar anesthesia for cataract extraction10.1186/s42077-021-00191-12090-925Xhttps://doaj.org/article/7336cc6852bb43c299eed63042c4f2952021-11-01T00:00:00Zhttps://doi.org/10.1186/s42077-021-00191-1https://doaj.org/toc/2090-925XAbstract Background The aim of the study was to evaluate the impact of addition of dexmedetomidine or magnesium sulphate to the standard local anesthetics mixture as a primary objective and to compare between both as a secondary objective utilizing the single-injection percutaneous technique for peribulbar block. In this prospective randomized double-blinded clinical trial (RCT), sixty patients, both sexes, aged 45 to 75, with an ASA of I to III, were scheduled for cataract extraction operation. They were divided into three equal groups; each received a single injection peribulbar block of a mixture of 0.5% bupivacaine (3 ml) + 2 percent lidocaine (3 ml) + 120 IU hyaluronidase + (control group (C): 0.5 ml of normal saline; group D: 50 μg of dexmedetomidine; group M: 50 mg of magnesium sulphate in 0.5 ml) with a total injected volume of 7 ml each. The duration of sensory, motor block, need for supplementary doses, hemodynamics, and satisfaction of patients and surgeons were assessed. Results For the primary outcome, both the dexmedetomidine and magnesium groups revealed statistically significant differences from the control group with shorter onsets of sensory block and lid akinesia (p value< 0.001 for both), shorter onset of globe akinesia for dexmedetomidine (p value<0.001) and for magnesium sulphate (p value=0.022), prolonged duration of lid and globe akinesia and sensory block (p value<0.001), better patient satisfaction (p value=0.044) but insignificant difference regarding surgeons’ satisfaction (p value= 0.117) and a less frequent, but statistically insignificant need for supplementary injection (p value=0.075). The demographic and clinical hemodynamics and oxygen saturation parameters were comparable between the three groups. For the secondary outcome, dexmedetomidine was superior to magnesium sulphate regarding onset of globe and lid akinesia (p value= 0.047 and 0.003, respectively), and durations of globe akinesia and sensory block (p value= 0.02 and 0.016, respectively). No complications related to the drugs or procedure were recorded. Conclusions When compared to 50 mg magnesium sulphate, dexmedetomidine at a dose of 50 μg is a superior adjunct to local anesthetic combination in peribulbar block for cataract procedures in terms of start and duration of peribulbar block.Aya Abuelyossr M.N. A. MohammadKhaled M. MaghawryMaha Sadek ElderhMai Mohsen AbdulAzizSpringerOpenarticleMagnesium sulphateDexmedetomidinePeribulbar blockCataract extractionAnesthesiologyRD78.3-87.3Medical emergencies. Critical care. Intensive care. First aidRC86-88.9ENAin Shams Journal of Anesthesiology, Vol 13, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic Magnesium sulphate
Dexmedetomidine
Peribulbar block
Cataract extraction
Anesthesiology
RD78.3-87.3
Medical emergencies. Critical care. Intensive care. First aid
RC86-88.9
spellingShingle Magnesium sulphate
Dexmedetomidine
Peribulbar block
Cataract extraction
Anesthesiology
RD78.3-87.3
Medical emergencies. Critical care. Intensive care. First aid
RC86-88.9
Aya Abuelyossr M.
N. A. Mohammad
Khaled M. Maghawry
Maha Sadek Elderh
Mai Mohsen AbdulAziz
Dexmedetomidine versus magnesium sulphate as an adjuvant to local anesthesia in single-injection percutaneous peribulbar anesthesia for cataract extraction
description Abstract Background The aim of the study was to evaluate the impact of addition of dexmedetomidine or magnesium sulphate to the standard local anesthetics mixture as a primary objective and to compare between both as a secondary objective utilizing the single-injection percutaneous technique for peribulbar block. In this prospective randomized double-blinded clinical trial (RCT), sixty patients, both sexes, aged 45 to 75, with an ASA of I to III, were scheduled for cataract extraction operation. They were divided into three equal groups; each received a single injection peribulbar block of a mixture of 0.5% bupivacaine (3 ml) + 2 percent lidocaine (3 ml) + 120 IU hyaluronidase + (control group (C): 0.5 ml of normal saline; group D: 50 μg of dexmedetomidine; group M: 50 mg of magnesium sulphate in 0.5 ml) with a total injected volume of 7 ml each. The duration of sensory, motor block, need for supplementary doses, hemodynamics, and satisfaction of patients and surgeons were assessed. Results For the primary outcome, both the dexmedetomidine and magnesium groups revealed statistically significant differences from the control group with shorter onsets of sensory block and lid akinesia (p value< 0.001 for both), shorter onset of globe akinesia for dexmedetomidine (p value<0.001) and for magnesium sulphate (p value=0.022), prolonged duration of lid and globe akinesia and sensory block (p value<0.001), better patient satisfaction (p value=0.044) but insignificant difference regarding surgeons’ satisfaction (p value= 0.117) and a less frequent, but statistically insignificant need for supplementary injection (p value=0.075). The demographic and clinical hemodynamics and oxygen saturation parameters were comparable between the three groups. For the secondary outcome, dexmedetomidine was superior to magnesium sulphate regarding onset of globe and lid akinesia (p value= 0.047 and 0.003, respectively), and durations of globe akinesia and sensory block (p value= 0.02 and 0.016, respectively). No complications related to the drugs or procedure were recorded. Conclusions When compared to 50 mg magnesium sulphate, dexmedetomidine at a dose of 50 μg is a superior adjunct to local anesthetic combination in peribulbar block for cataract procedures in terms of start and duration of peribulbar block.
format article
author Aya Abuelyossr M.
N. A. Mohammad
Khaled M. Maghawry
Maha Sadek Elderh
Mai Mohsen AbdulAziz
author_facet Aya Abuelyossr M.
N. A. Mohammad
Khaled M. Maghawry
Maha Sadek Elderh
Mai Mohsen AbdulAziz
author_sort Aya Abuelyossr M.
title Dexmedetomidine versus magnesium sulphate as an adjuvant to local anesthesia in single-injection percutaneous peribulbar anesthesia for cataract extraction
title_short Dexmedetomidine versus magnesium sulphate as an adjuvant to local anesthesia in single-injection percutaneous peribulbar anesthesia for cataract extraction
title_full Dexmedetomidine versus magnesium sulphate as an adjuvant to local anesthesia in single-injection percutaneous peribulbar anesthesia for cataract extraction
title_fullStr Dexmedetomidine versus magnesium sulphate as an adjuvant to local anesthesia in single-injection percutaneous peribulbar anesthesia for cataract extraction
title_full_unstemmed Dexmedetomidine versus magnesium sulphate as an adjuvant to local anesthesia in single-injection percutaneous peribulbar anesthesia for cataract extraction
title_sort dexmedetomidine versus magnesium sulphate as an adjuvant to local anesthesia in single-injection percutaneous peribulbar anesthesia for cataract extraction
publisher SpringerOpen
publishDate 2021
url https://doaj.org/article/7336cc6852bb43c299eed63042c4f295
work_keys_str_mv AT ayaabuelyossrm dexmedetomidineversusmagnesiumsulphateasanadjuvanttolocalanesthesiainsingleinjectionpercutaneousperibulbaranesthesiaforcataractextraction
AT namohammad dexmedetomidineversusmagnesiumsulphateasanadjuvanttolocalanesthesiainsingleinjectionpercutaneousperibulbaranesthesiaforcataractextraction
AT khaledmmaghawry dexmedetomidineversusmagnesiumsulphateasanadjuvanttolocalanesthesiainsingleinjectionpercutaneousperibulbaranesthesiaforcataractextraction
AT mahasadekelderh dexmedetomidineversusmagnesiumsulphateasanadjuvanttolocalanesthesiainsingleinjectionpercutaneousperibulbaranesthesiaforcataractextraction
AT maimohsenabdulaziz dexmedetomidineversusmagnesiumsulphateasanadjuvanttolocalanesthesiainsingleinjectionpercutaneousperibulbaranesthesiaforcataractextraction
_version_ 1718419251852738560